Qubigen to Attend BIO International Convention 2026 in San Diego

Qubigen is excited to announce our participation in the upcoming BIO International Convention 2026 in San Diego, taking place from June 22-26, 2026.

A Global Stage for Biotechnology Innovation

The BIO International Convention is the world’s biggest and most comprehensive biotechnology event, representing the full breadth of the global biotech ecosystem, bringing together over 20,000 industry leaders from biotech, pharmaceuticals, academia, and investment communities. The convention serves as a powerful platform for showcasing innovation, fostering partnerships, and advancing the future of life sciences on a global scale.

Qubigen’s Federated AI Technology in Focus at BIO 2026

At the core of Qubigen’s mission is its patented privacy-preserving Federated AI platform. It enables organizations within the biopharma ecosystem to benefit from Qubigen’s tailored AI Engines that learn directly from client-specific data, without ever moving or exposing it.

Unlike generalist AI models, Qubigen’s tailored AI engines deliver meaningful accuracy uplifts on the exact data that matters in real drug discovery programs, while maintaining complete data sovereignty and IP protection. Combined with GPU-accelerated quantum chemistry and advanced molecular modelling, the platform accelerates hit-to-lead, SAR/SPR, and lead optimization with measurable gains in speed and predictability, potentially shaving years off traditional chemistry approaches.

Join Us in San Diego

Qubigen will be represented at BIO 2026 by CEO Jonathan Hall, and David Brooks, Product and Operations manager from their core team, joined by several board members and representatives. Qubigen is looking to engage with a broad range of biopharma partners, investors, and strategic leaders. Qubigen’s has an ongoing commitment to expanding its international presence and to building high-value partnerships across the biotech ecosystem.

If you’re attending BIO 2026 and interested in connecting around partnerships or collaboration opportunities, please reach out to us to schedule a meeting during the event, or connect with us via the BIO Partnering™ platform.

Don’t hesitate, however, to reach out to us directly:

jonathan.hall@qubigen.com

david.brooks@qubigen.com

Qubigen - accelerate drug design without exposing secrets

Qubigen builds and hosts powerful, privacy-preserving AI Engines, turning discrete client-specific data into a competitive edge.

Whether you're advancing active programs, reviving dormant data, or starting from scratch, Qubigen’s secure Federated AI and quantum chemistry platform can help you identify, optimize, and accelerate the path to promising lead drug candidates. Get in touch to explore how we can support your next development.

enquiries@qubigen.com